Past Meeting Highlights

Congratulations 2022 Abstract Competition Winners!

Oral Presentations

1st Place Oral
Shista Priyadarshini, MD
Guthrie Robert Packer Hospital
A Quality Improvement Initiative to Improve Lung Cancer Screening Rates in a Community-Based Clinic

e-Posters

1st Place Poster
Swe Swe Hlaing, MD
Crozer Chester Medical Center
Are the NCCN Guidelines Regarding Use of Immunotherapy for Stage III NSCLC in a Community Setting Being Followed?

The Pennsylvania Society of Oncology and Hematology gratefully acknowledges the following organizations for supporting PSOH’s 2022 Annual Meeting

10K Corporate Members

Bristol Myers Squibb
Daiichi Sankyo, Inc.
Gilead
Janssen Pharmaceutical
Companies of Johnson & Johnson
Merck
Regeneron
Seagen

5K Corporate Members

Astellas Oncology
AstraZeneca
Aveo Oncology
Exelixis
Kyowa Kirin, Inc.
MacroGenics, Inc.
Pfizer Oncology
Sanofi

Exhibitors

Adaptive Biotechnologies
Alexion
Alexion Pharmaceuticals
Amgen
Bayer
BeiGene USA
Blueprint Medicines
BTG Specialty Pharmaceuticals
Caris Life Sciences
Coherus Biosciences
Eisai Inc.
EMD Serono
Exact Sciences
Foundation Medicine, Inc.

Fox Chase Cancer Center
Genentech
Guardant Health
Immunocore
Incyte Corp
Ipsen Biopharmaceuticals
Janssen Pharmaceuticals, Inc.
Karius
Lilly
Massive Bio
Pharmacosmos Therapeutics, Inc.
Sanofi
Sobi
Stemline Therapeutics